1
|
Dimethylmyricacene: An In Vitro and In Silico Study of a Semisynthetic Non-Camptothecin Derivative Compound, Targeting Human DNA Topoisomerase 1B. Cells 2022; 11:cells11213486. [DOI: 10.3390/cells11213486] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2022] [Revised: 10/31/2022] [Accepted: 11/02/2022] [Indexed: 11/06/2022] Open
Abstract
Human topoisomerase 1B regulates the topological state of supercoiled DNA enabling all fundamental cell processes. This enzyme, which is the unique molecular target of the natural anticancer compound camptothecin, acts by nicking one DNA strand and forming a transient protein–DNA covalent complex. The interaction of human topoisomerase 1B and dimethylmyricacene, a compound prepared semisynthetically from myricanol extracted from Myrica cerifera root bark, was investigated using enzymatic activity assays and molecular docking procedures. Dimethylmyricacene was shown to inhibit both the cleavage and the religation steps of the enzymatic reaction, and cell viability of A-253, FaDu, MCF-7, HeLa and HCT-116 tumor cell lines.
Collapse
|
2
|
Liu H, Wang C. The genus Asarum: A review on phytochemistry, ethnopharmacology, toxicology and pharmacokinetics. JOURNAL OF ETHNOPHARMACOLOGY 2022; 282:114642. [PMID: 34537281 DOI: 10.1016/j.jep.2021.114642] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/30/2021] [Revised: 08/28/2021] [Accepted: 09/11/2021] [Indexed: 06/13/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE In essentially every quadrant of the globe, many species of genus Asarum are used as a common herbal medicine and appear in many formulas or Kampo. Crude drug from several medicinal plants of genus Asarum (MA) known as Asari Radix et Rhizoma (ARR) has been proven to have the functions of dispelling cold, relieving pain, and reducing phlegm according to Traditional Chinese Medicine (TCM) theory for thousands of years. AIM OF THE STUDY This article reviews the ethnopharmacology, phytochemistry, pharmacology, toxicology and metabolic kinetics related research of genus Asarum to evaluate its ethnopharmacology use and future opportunities for research. MATERIALS AND METHODS Information on relevant studies of the genus Asarum was gathered via the Internet using Baidu Scholar, Web of Science, Elsevier, ResearchGate, ACS, Pudmed and Chinese National Knowledge Infrastructure (CNKI). Additionally, information was also obtained from some local books, PhD, MS's dissertations and Pharmacopeias. RESULTS The genus Asarum has played an important role in herbal treatment. At present, more than 277 compounds have been isolated or identified from genus Asarum. Among them, volatile oil and lignans are the major active constituents and important chemotaxonomic markers. Modern pharmacological studies indicated that genus Asarum and its active compounds possess a wide range of pharmacological effects, especially analgesic, anti-inflammatory, neuroprotective, cardiovascular protection, antitussive, immunosuppressive, anti-tumor, and microbicidal activities. CONCLUSIONS Based on this review, therapeutic potential of genus Asarum has been demonstrated with the pharmacological effects on inflammation, CNS, respiratory regulation, cardiovascular diseases, cancer and microbial infection. The available literature showed that the major activities of the genus Asarum can be attributed to the active lignans and essential oils. Further in-depth studies on the aspects of the genus for mechanism of actions, metabolism, pharmacokinetics, toxicology, drug interactions, and clinical trials are still limited, thereby intensive research and assessments should be performed.
Collapse
Affiliation(s)
- Hanze Liu
- Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, The MOE Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines, Shanghai R&D Centre for Standardization of Chinese Medicines, 1200 Cailun Road, Shanghai, 201203, China
| | - Changhong Wang
- Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, The MOE Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines, Shanghai R&D Centre for Standardization of Chinese Medicines, 1200 Cailun Road, Shanghai, 201203, China.
| |
Collapse
|
3
|
Ottaviani A, Iacovelli F, Fiorani P, Desideri A. Natural Compounds as Therapeutic Agents: The Case of Human Topoisomerase IB. Int J Mol Sci 2021; 22:4138. [PMID: 33923641 PMCID: PMC8073192 DOI: 10.3390/ijms22084138] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2021] [Revised: 04/12/2021] [Accepted: 04/13/2021] [Indexed: 11/25/2022] Open
Abstract
Natural products are widely used as source for drugs development. An interesting example is represented by natural drugs developed against human topoisomerase IB, a ubiquitous enzyme involved in many cellular processes where several topological problems occur due the formation of supercoiled DNA. Human topoisomerase IB, involved in the solution of such problems relaxing the DNA cleaving and religating a single DNA strand, represents an important target in anticancer therapy. Several natural compounds inhibiting or poisoning this enzyme are under investigation as possible new drugs. This review summarizes the natural products that target human topoisomerase IB that may be used as the lead compounds to develop new anticancer drugs. Moreover, the natural compounds and their derivatives that are in clinical trial are also commented on.
Collapse
Affiliation(s)
- Alessio Ottaviani
- Department of Biology, University of Rome Tor Vergata, Via Della Ricerca Scientifica, 00133 Rome, Italy; (F.I.); (P.F.); (A.D.)
| | - Federico Iacovelli
- Department of Biology, University of Rome Tor Vergata, Via Della Ricerca Scientifica, 00133 Rome, Italy; (F.I.); (P.F.); (A.D.)
| | - Paola Fiorani
- Department of Biology, University of Rome Tor Vergata, Via Della Ricerca Scientifica, 00133 Rome, Italy; (F.I.); (P.F.); (A.D.)
- Institute of Translational Pharmacology, National Research Council, CNR, Via Del Fosso del Cavaliere 100, 00133 Rome, Italy
| | - Alessandro Desideri
- Department of Biology, University of Rome Tor Vergata, Via Della Ricerca Scientifica, 00133 Rome, Italy; (F.I.); (P.F.); (A.D.)
| |
Collapse
|
4
|
Oliveira CG, Romero-Canelón I, Silva MM, Coverdale JPC, Maia PIS, Batista AA, Castelli S, Desideri A, Sadler PJ, Deflon VM. Palladium(ii) complexes with thiosemicarbazones derived from pyrene as topoisomerase IB inhibitors. Dalton Trans 2020; 48:16509-16517. [PMID: 31670343 DOI: 10.1039/c9dt02570g] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
New palladium complexes with thiosemicarbazonate ligands derived from pyrene exhibit potent antiproliferative activity against A2780 and cisplatin-resistant A2780Cis human ovarian cancer cells, which is dependent on substituent groups of the thiosemicarbazone ligands. Cellular accumulation and distribution studies confirmed that palladium enters the cell nucleus. DNA and topoisomerase IB studies show that one complex is a potent TopIB inhibitor, with selectivity for cancer versus normal cells.
Collapse
Affiliation(s)
- Carolina G Oliveira
- São Carlos Institute of Chemistry, University of São Paulo, 13560-970, São Carlos, Brazil.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Yu Q, Chen Y, Yang H, Zhang HL, Agama K, Pommier Y, An LK. The antitumor activity of CYB-L10, a human topoisomerase IB catalytic inhibitor. J Enzyme Inhib Med Chem 2019; 34:818-822. [PMID: 30907213 PMCID: PMC6442119 DOI: 10.1080/14756366.2018.1516651] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2018] [Revised: 08/20/2018] [Accepted: 08/22/2018] [Indexed: 01/13/2023] Open
Abstract
DNA topoisomerase IB (TOP1) is a validated target for discovery and development of antitumor agents. Four TOP1 poisons are clinically used for tumor treatment now. In spite of their effectiveness in solid tumors, these camptothecin (CPT) poisons suffer from many shortcomings. Therefore, many investigations have focused on the discoveries of non-CPT poisons and catalytic inhibitors. Herein, we systematically study the antitumor activity of CYB-L10, a novel indolizinoquinolinedione TOP1 catalytic inhibitor discovered in our laboratory. The results indicated that CYB-L10 mainly acts on TOP1 in cancer cells and is not a substrate of the P-glycoprotein. In addition, CYB-L10 can induce apoptosis of HCT116 cells, shows high cytotoxicity against 60 human clinical cancer cell lines (NCI60) with the mean-graph midpoint for growth inhibition of all cancer cell lines of 0.050 µM concentration and obvious antitumor efficiency in vivo in the HCT116 xenograft model.
Collapse
Affiliation(s)
- Qian Yu
- School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China
| | - Yu Chen
- School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China
| | - Hui Yang
- School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China
| | - Hong-Li Zhang
- School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China
| | - Keli Agama
- Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States
| | - Yves Pommier
- Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States
| | - Lin-Kun An
- School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China
| |
Collapse
|
6
|
da Silva MM, de Camargo MS, Correa RS, Castelli S, De Grandis RA, Takarada JE, Varanda EA, Castellano EE, Deflon VM, Cominetti MR, Desideri A, Batista AA. Non-mutagenic Ru(ii) complexes: cytotoxicity, topoisomerase IB inhibition, DNA and HSA binding. Dalton Trans 2019; 48:14885-14897. [DOI: 10.1039/c9dt01905g] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Herein we discuss five ruthenium(ii) complexes with good cytotoxicity against cancer cells.
Collapse
Affiliation(s)
| | | | - Rodrigo S. Correa
- Departamento de Química
- Universidade Federal de Ouro Preto
- Ouro Preto
- Brazil
| | - Silvia Castelli
- Dipartimentodi Biologia
- UniversitàTorVergatadi Roma
- 00133 Rome
- Italy
| | - Rone A. De Grandis
- Departamento de Ciências Biológicas
- Faculdade de Ciências Farmacêuticas
- UNESP
- Araraquara
- Brazil
| | | | - Eliana A. Varanda
- Departamento de Ciências Biológicas
- Faculdade de Ciências Farmacêuticas
- UNESP
- Araraquara
- Brazil
| | | | - Victor M. Deflon
- Instituto de Química de São Carlos
- Universidade de São Paulo
- São Carlos
- Brazil
| | - Marcia R. Cominetti
- Departamento de Gerontologia
- Universidade Federal de São Carlos
- São Carlos
- Brazil
| | | | - Alzir A. Batista
- Departamento de Química
- Universidade Federal de São Carlos
- São Carlos
- Brazil
| |
Collapse
|
7
|
Castelli S, Gonçalves MB, Katkar P, Stuchi GC, Couto RAA, Petrilli HM, da Costa Ferreira AM. Comparative studies of oxindolimine-metal complexes as inhibitors of human DNA topoisomerase IB. J Inorg Biochem 2018; 186:85-94. [PMID: 29860208 DOI: 10.1016/j.jinorgbio.2018.05.012] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2018] [Revised: 05/18/2018] [Accepted: 05/20/2018] [Indexed: 12/17/2022]
Affiliation(s)
- Silvia Castelli
- Department of Biology, University of Rome Tor Vergata, Via Della Ricerca Scientifica, Rome 00133, Italy
| | - Marcos Brown Gonçalves
- Departamento de Física, Universidade Tecnológica Federal do Paraná, 80230-901 Curitiba, PR, Brazil
| | - Prafulla Katkar
- Department of Biology, University of Rome Tor Vergata, Via Della Ricerca Scientifica, Rome 00133, Italy
| | - Gabriela Cristina Stuchi
- Departamento de Química Fundamental, Instituto de Química, Universidade de São Paulo, 05508-000 São Paulo, SP, Brazil
| | - Ricardo Alexandre Alves Couto
- Departamento de Química Fundamental, Instituto de Química, Universidade de São Paulo, 05508-000 São Paulo, SP, Brazil
| | - Helena Maria Petrilli
- Departamento de Física dos Materiais e Mecânica, Instituto de Física, Universidade de São Paulo, 05508-090 São Paulo, SP, Brazil
| | - Ana Maria da Costa Ferreira
- Departamento de Química Fundamental, Instituto de Química, Universidade de São Paulo, 05508-000 São Paulo, SP, Brazil.
| |
Collapse
|
8
|
Affiliation(s)
- Giovanni Capranico
- Department
of Pharmacy and Biotechnology, University of Bologna, Via Belmeloro
8/2, 40126 Bologna, Italy
| | - Jessica Marinello
- Department
of Pharmacy and Biotechnology, University of Bologna, Via Belmeloro
8/2, 40126 Bologna, Italy
| | - Giovanni Chillemi
- SCAI
SuperComputing Applications and Innovation Department, Cineca, Via dei Tizii 6, 00185 Rome, Italy
| |
Collapse
|
9
|
Advances in the Chemistry of Natural and Semisynthetic Topoisomerase I/II Inhibitors. STUDIES IN NATURAL PRODUCTS CHEMISTRY 2017. [DOI: 10.1016/b978-0-444-63929-5.00002-4] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
|
10
|
nZ,(n + 4)Z-Dienoic fatty acids: a new method for the synthesis and inhibitory action on topoisomerase I and IIα. Med Chem Res 2015. [DOI: 10.1007/s00044-015-1446-1] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
|
11
|
D’yakonov VA, Dzhemileva LU, Makarov AA, Mulukova AR, Baev DS, Khusnutdinova EK, Tolstikova TG, Dzhemilev UM. Stereoselective synthesis of 11-phenylundeca-5Z,9Z-dienoic acid and investigation of its human topoisomerase I and IIα inhibitory activity. Bioorg Med Chem Lett 2015; 25:2405-8. [DOI: 10.1016/j.bmcl.2015.04.011] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2015] [Revised: 03/31/2015] [Accepted: 04/02/2015] [Indexed: 12/19/2022]
|
12
|
Vieira S, Castelli S, Falconi M, Takarada J, Fiorillo G, Buzzetti F, Lombardi P, Desideri A. Role of 13-(di)phenylalkyl berberine derivatives in the modulation of the activity of human topoisomerase IB. Int J Biol Macromol 2015; 77:68-75. [PMID: 25783020 DOI: 10.1016/j.ijbiomac.2015.02.051] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2014] [Revised: 02/26/2015] [Accepted: 02/28/2015] [Indexed: 12/25/2022]
Abstract
Topoisomerases IB are anticancer and antimicrobial targets whose inhibition by several natural and non-natural compounds has been documented. The inhibition effect by berberine and some 13-(di)phenylalkyl berberine derivatives has been tested towards human topoisomerase IB. Derivatives belonging to the 13-diphenylalkyl series display an efficient inhibition of the DNA relaxation and cleavage step, that increases upon pre-incubation with the enzyme. The religation step of the enzyme catalytic cycle is not affected by compounds and only slightly upon pre-incubation. The binding of the protein to the DNA substrate occurs also in the presence of the compounds, as monitored by a DNA shift assay, indicating that the compounds are not able to inhibit the formation of the enzyme-DNA complex but that they act as catalytic inhibitors.
Collapse
Affiliation(s)
- Sara Vieira
- University of Rome Tor Vergata, Department of Biology, Via Della Ricerca Scientifica, 00133 Rome, Italy
| | - Silvia Castelli
- University of Rome Tor Vergata, Department of Biology, Via Della Ricerca Scientifica, 00133 Rome, Italy
| | - Mattia Falconi
- University of Rome Tor Vergata, Department of Biology, Via Della Ricerca Scientifica, 00133 Rome, Italy
| | - Jéssica Takarada
- University of Rome Tor Vergata, Department of Biology, Via Della Ricerca Scientifica, 00133 Rome, Italy
| | - Gaetano Fiorillo
- Naxospharma srl, Via G. Di Vittorio, 70, 20026 Novate Milanese, Italy
| | - Franco Buzzetti
- Naxospharma srl, Via G. Di Vittorio, 70, 20026 Novate Milanese, Italy
| | - Paolo Lombardi
- Naxospharma srl, Via G. Di Vittorio, 70, 20026 Novate Milanese, Italy
| | - Alessandro Desideri
- University of Rome Tor Vergata, Department of Biology, Via Della Ricerca Scientifica, 00133 Rome, Italy.
| |
Collapse
|
13
|
Katkar P, Coletta A, Castelli S, Sabino GL, Couto RAA, Ferreira AMDC, Desideri A. Effect of oxindolimine copper(II) and zinc(II) complexes on human topoisomerase I activity. Metallomics 2014; 6:117-25. [PMID: 24172750 DOI: 10.1039/c3mt00099k] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The ability of oxindolimine copper(II) and zinc(II) complexes, known to have antitumor activity, to inhibit human topoisomerase IB has been tested through enzymatic kinetic assays and molecular docking simulations. These copper and zinc compounds are able to inhibit remarkably the cleavage reaction and only partially the religation step, the copper compound being more efficient than the zinc one. A complete inhibition activity of the cleavage is only obtained when the enzyme is pre-incubated with the compound, the inhibition being irreversible and reversible for the copper and zinc compounds, respectively. The relative stability of such complexes was estimated by competitive equilibria with human serum albumin (HSA), monitored by CD spectroscopy. The copper species shows a log KCuL = 17.2, while the analogous zinc complex exhibits a log KZnL = 7.2. Molecular docking simulation studies show that the almost square planar geometry of the copper compound allows a direct coordination of the metal with two amino acids (Glu492, Asp563) of the enzyme at variance of the zinc compound which has a more tetrahedral geometry. Altogether, the data indicate that the different coordination geometry achieved by the two transition metal ions has an important role in modulating their efficiency as topoisomerase I inhibitors.
Collapse
Affiliation(s)
- Prafulla Katkar
- Dipartimento di Biologia, Università Tor Vergata di Roma, 00173 Roma, Italy.
| | | | | | | | | | | | | |
Collapse
|
14
|
Nimesh H, Sur S, Sinha D, Yadav P, Anand P, Bajaj P, Virdi JS, Tandon V. Synthesis and Biological Evaluation of Novel Bisbenzimidazoles as Escherichia coli Topoisomerase IA Inhibitors and Potential Antibacterial Agents. J Med Chem 2014; 57:5238-57. [DOI: 10.1021/jm5003028] [Citation(s) in RCA: 54] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Affiliation(s)
- Hemlata Nimesh
- Department
of Chemistry, University of Delhi, Delhi 110 007, India
| | - Souvik Sur
- Department
of Chemistry, University of Delhi, Delhi 110 007, India
| | - Devapriya Sinha
- Department
of Chemistry, University of Delhi, Delhi 110 007, India
| | - Pooja Yadav
- Department
of Chemistry, University of Delhi, Delhi 110 007, India
| | - Prachi Anand
- Department of Chemistry & Biochemistry, CUNY−Hunter College, New York, New York 10065, United States
| | - Priyanka Bajaj
- Department
of Microbiology, University of Delhi, Delhi 110 021, India
| | | | - Vibha Tandon
- Department
of Chemistry, University of Delhi, Delhi 110 007, India
- Special
Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi 110 067, India
| |
Collapse
|